← Back to Search

Bandage Contact Lens

Group 1 for Corneal Abrasions

Phase 2
Waitlist Available
Research Sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours post treatment
Awards & highlights

Study Summary

Two percent of all patients presenting to the Emergency Departments have complaints involving the eye. Corneal abrasions are a common diagnosis with patients with eye pain and often cause significant discomfort. Current treatment includes a thorough evaluation of the eye followed by patching, empiric antibiotics, cycloplegics and oral pain medicines. This study will be a randomized controlled trial to determine the safety and efficacy of BCLs. It will involve the initial patient evaluation followed by a return visit to the Emergency Department within 36 hours for re-examination. At each visit, the patient will be assessed for the size and location of the abrasion along with their report of pain using a visual analog scale. Data will be recorded on a standard data collection sheet. Telephone contact will be made at 30 days to ensure resolution of abrasion and that no complications ensued.

Eligible Conditions
  • Corneal Abrasions
  • Eye Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain scale
Secondary outcome measures
Corneal defect size
Pain medication needed

Trial Design

2Treatment groups
Active Control
Group I: Group 1Active Control2 Interventions
1. Standard care
Group II: Group 2Active Control3 Interventions
Standard care Bandage contact lens

Find a Location

Who is running the clinical trial?

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterLead Sponsor
101 Previous Clinical Trials
46,241 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Apr 2025